Prognostic Value of Phosphorylated Akt and Survivin Expression in Gastric Adenocarcinoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : pAkt (the phosphorylated form of the proto-oncogene protein c-akt) and survivin (human BIRC5 protein) are candidate apoptosis-related molecules that may be responsible for cancer progression. The aim of this study was to determine the expression of pAkt and survivin in malignant stomach neoplasm, and their value as prognostic indicators of cancer. Methods : The expression of pAkt and survivin in 144 cases of gastric cancer was detected by immunohistochemistry and compared with established clinicopathological parameters and prognosis of this disease. Results : Expression of pAkt showed significant correlations with depth of invasion, lymph node and distant metastasis, as well as the stage (p < 0.05 for all three correlations), but not with the Lauren classification. Survivin expression closely correlated with histological type, Lauren classification, depth of invasion, metastasis, and stage (p < 0.05 for all). The overall survival of patients with pAkt/survivin expression was inferior to that of patients with loss of pAkt/survivin expression. Cox multivariate analysis demonstrated a significant correlation between stage (p = 0.04), survivin expression (p = 0.02), and prognosis. Conclusions : Patients with pAkt/survivin expression in gastric cancer are at increased risk of cancer-related mortality via the apoptosis resistance pathway. Expression of pAkt and survivin could be used as a prognostic indicator for gastric cancer.
Abstract
Background : pAkt (the phosphorylated form of the proto-oncogene protein c-akt) and survivin (human BIRC5 protein) are candidate apoptosis-related molecules that may be responsible for cancer progression. The aim of this study was to determine the expression of pAkt and survivin in malignant stomach neoplasm, and their value as prognostic indicators of cancer. Methods : The expression of pAkt and survivin in 144 cases of gastric cancer was detected by immunohistochemistry and compared with established clinicopathological parameters and prognosis of this disease. Results : Expression of pAkt showed significant correlations with depth of invasion, lymph node and distant metastasis, as well as the stage (p < 0.05 for all three correlations), but not with the Lauren classification. Survivin expression closely correlated with histological type, Lauren classification, depth of invasion, metastasis, and stage (p < 0.05 for all). The overall survival of patients with pAkt/survivin expression was inferior to that of patients with loss of pAkt/survivin expression. Cox multivariate analysis demonstrated a significant correlation between stage (p = 0.04), survivin expression (p = 0.02), and prognosis. Conclusions : Patients with pAkt/survivin expression in gastric cancer are at increased risk of cancer-related mortality via the apoptosis resistance pathway. Expression of pAkt and survivin could be used as a prognostic indicator for gastric cancer.
참고문헌 (30)
- Thompson CB, "Apoptosis in the pathogenesis and treatment of disease", Science, 267, pp.1456~1462 (1995)
- Fenoglio-Preiser C, "Gastric carcinoma. In: Pathology and genetics of tumours of the digestive system. 3rd ed", pp.39~52 (2000), IARC Press
- van der Woude CJ, "Chronic inflammation,apoptosis and(pre-)malignant lesions in the gastrointestinal tract", Apoptosis, 9, pp.123~130 (2004)
- Vivanco I, "The phosphatidylinositol 3-Kinase AKT pathway in human cancer", Nat Rev Cancer, 2, pp.489~501 (2002)
- Pérez-Tenorio G, "Activation of AKT", PKB in breast cancer predicts a worse outcome among endocrine treated patients, 2002, pp.86, 540~545
- Kreisberg JI, "Phosphorylation of Akt(Ser473)is an excellent predictor of poor clinical outcome in prostate cancer", Cancer Res, 64, pp.5232~5236 (2004)
- Tanno S, "AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells", Cancer Res, 61, pp.589~593 (2001)
- Park BK, "Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells", Cancer Res, 61, pp.7647~7653 (2001)
- Thant AA, "Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3KAkt pathways in ovarian cancer cells", Clin Exp Metastasis, 18, pp.423~428 (2000)
- Grille SJ, "The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines", Cancer Res, 63, pp.2172~2178 (2003)
- Greene FL, "AJCC cancer staging manual. 6th ed", pp.99~106 (2002), Springer-Verlag
- Freitas S, "Studies of apurinic", apyrimidinic endonuclease, Clin Cancer Res, pp.2003, 9[DOI]
- Murthy SS, "Mapping of AKT3,encoding a member of the Akt", protein kinase B family,to human and rodent chromosomes by fluorescence in situ hybridization, 2000, pp.88, 38~40
- Alessi DR, "Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha", Curr Biol, 7, pp.261~269 (1997)
- Murakami D, "Expression of phosphorylated Akt(pAkt)in gastric carcinoma predicts prognosis and efficacy of chemotherapy", Gastric Cancer, 10, pp.45~51 (2007)
- Cinti C, "Activated Akt as an indicator of prognosis in gastric cancer", Virchows Arch, 453, pp.449~455 (2008)
- Ambrosini G, "A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma", Nat Med, 3, pp.917~921 (1997)
- Shin S, "An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7", Biochemistry, 40, pp.1117~1123 (2001)
- Li F, "Survivin study:an update of"what is the next wave"?", J Cell Physiol, 208, pp.476~486 (2006)
- Adida C, "Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation", Am J Pathol, 152, pp.43~49 (1998)
- Grabowski P, "Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma", Br J Cancer, 88, pp.115~119 (2003)
- Meng H, "Prognostic significance and different properties of survivin splicing variants in gastric cancer", Cancer Lett, 216, pp.147~155 (2004)
- Ponnelle T, "Cellular localisation of survivin:impact on the prognosis in colorectal cancer", J Cancer Res Clin Oncol, 131, pp.504~510 (2005)
- Soengas MS, "Apoptosis and melanoma chemoresistance", Oncogene, 22, pp.3138~3151 (2003)
- Notarbartolo M, "Expression of the IAPs in multidrug resistant tumor cells", Oncol Rep, 11, pp.133~136 (2004)
- Papapetropoulos A, "Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt", survivin pathway, 2000, pp.275, 9102~9105
- Carter BZ, "Cytokine-regulated expression of survivin in myeloid leukemia", Blood, 97, pp.2784~2790 (2001)
- Fornaro M, "Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT", survivin pathway, 2003, pp.278, 50402~50411
- Mitsiades CS, "Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1", Akt signaling in human multiple myeloma cells:therapeutic implications, 2002, pp.21, 5673~5683
- Kanda N, "STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells", Oncogene, 23, pp.4921~4929 (2004)